Scientific Program
Takeda’s Industry Symposium

Improving patient care through optimized treatment approaches in multiple myeloma: debating current key issues
Industry Symposium (Multiple Myeloma) organised by Takeda Pharmaceuticals International AG

 

Friday 21 April, 12.30–13.30

12:30 – 12:33                 Welcome and introduction

                                          Professor Arnon Nagler, Chaim Sheba Medical Center, Tel Hashomer, Israel

Debate 1: Use of continuous vs. fixed-duration therapy as treatment approaches in multiple myeloma

12:33 – 12:40                 Presentation outlining case for continuous duration of therapy

                                          Professor Evangelos Terpos, University of Athens School of Medicine, Greece


12:40 – 12:47                 Presentation outlining case for fixed duration of therapy

                                          Professor Xavier Leleu, Hopital La Milétrie, Poitiers (CHU), France


12:47 – 13:00                 Debate including Q&A from the audience

                                          Moderator: Professor Arnon Nagler

                                          Speakers: Professor Evangelos Terpos and Professor Xavier Leleu

Debate 2: Use of triplet vs. doublet combination regimens for the treatment of relapsed/refractory multiple myeloma

 

13:00 – 13:07                 Presentation outlining case for triplet combinations in RRMM

                                          Professor Xavier Leleu


13:07 – 13:14                 Presentation outlining case for doublet regimens in RRMM

                                          Professor Evangelos Terpos


13:14 – 13:28                 Debate including Q&A from the audience

                                          Moderator: Professor Arnon Nagler

                                          Speakers: Professor Evangelos Terpos and Professor Xavier Leleu


13:28                                Conclusions and summary / Meeting close

                                          Moderator: Professor Arnon Nagler

+972 3 555 0188

CME Congresses Ltd.

+972 3 540 1566

© COMy Multiple Myeloma Highlights 2017, a post-IMW summary congress